Dr. Camille Jackson

Claim this profile
Studies Serous Cystadenocarcinoma
Studies Relapse
1 reported clinical trial
2 drugs studied

Area of expertise

1Serous Cystadenocarcinoma
Camille Jackson has run 1 trial for Serous Cystadenocarcinoma. Some of their research focus areas include:
BRCA positive
BRCA negative
HRD positive
2Relapse
Camille Jackson has run 1 trial for Relapse. Some of their research focus areas include:
BRCA positive
BRCA negative
HRD positive

Clinical Trials Camille Jackson is currently running

More about Camille Jackson

Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Camille Jackson has experience with
  • Abemaciclib
  • Olaparib

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Camille Jackson specialize in?
Camille Jackson focuses on Serous Cystadenocarcinoma and Relapse. In particular, much of their work with Serous Cystadenocarcinoma has involved BRCA positive patients, or patients who are BRCA negative.
Is Camille Jackson currently recruiting for clinical trials?
Yes, Camille Jackson is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Camille Jackson has studied deeply?
Yes, Camille Jackson has studied treatments such as Abemaciclib, Olaparib.
What is the best way to schedule an appointment with Camille Jackson?
Apply for one of the trials that Camille Jackson is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.